학술논문
Cost Analysis of Teleophthalmology Screening for Diabetic Retinopathy Using Teleophthalmology Billing Codes
Document Type
Academic Journal
Author
Source
Ophthalmic Surgery, Lasers, and Imaging Retina. May, 2020, Vol. 51 Issue 5, pS26, p9 p.
Subject
Language
English
ISSN
2325-8160
Abstract
BACKGROUND AND OBJECTIVE: To evaluate the financial sustainability of teleophthalmology screening for diabetic retinopathy (DR) using telehealth billing codes. PATIENTS AND METHODS: The authors performed an Institutional Review Board-approved retrospective review of medical records, billing data, and quality metrics at the University of California Davis Health System from patients screened for DR through an internal medicine-based telemedicine program using CPT codes 92227 or 92228. RESULTS: A total of 290 patients received teleophthalmology screening over a 12-month period, resulting in an increase in the DR screening rate from 49% to 63% (P CONCLUSION: Sustainable teleophthalmology screening may be achieved by billing telehealth codes but only with health care incentive bonuses, patient referrals, and by accounting for the projected cost-savings of eliminating office visits. [Ophthalmic Surg Lasers Imaging Retina. 2020;51:S26–S34.]
Introduction Diabetic retinopathy (DR) is the most common cause of blindness in working-age adults in developed countries and is estimated to cost the United States $245 billion dollars annually in [...]
Introduction Diabetic retinopathy (DR) is the most common cause of blindness in working-age adults in developed countries and is estimated to cost the United States $245 billion dollars annually in [...]